Nanomaterials as potential transporters of HDAC inhibitors
Nanomedicine that combines technology with medical diagnostics and therapeutics is now advancing to greater heights for its significant potential in drug delivery. Epigenetic modifications that alter gene expressions patterns are often associated with disease progression and therapeutic resistance....
Saved in:
Main Authors: | Cristabelle De Souza (Author), Zhao Ma (Author), Aaron Raymond Lindstrom (Author), Biswa Prasun Chatterji (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021) -
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022) -
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
by: Omnia R. Elbatrawy, et al.
Published: (2023) -
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014)